Antireflux surgery versus medical management of gastro-oesophageal reflux after lung transplantation
European Journal of Cardio-Thoracic Surgery · 01.03.2023 · 63 (3)
DOI: 10.1093/ejcts/ezad063 ↗Kurz gefasst
Kommentar in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 21.02.2023. Verfasst von Deepika Razia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA. Hauptthemen laut MEDLINE: Gastroesophageal Reflux, Hernia, Hiatal, Lung Transplantation, Laparoscopy. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES Gastro-oesophageal reflux disease after lung transplantation may be associated with chronic lung allograft dysfunction. Aspiration may continue on medical management of reflux, but antireflux surgery potentially reduces all reflux. We compared outcomes between medical and surgical management of reflux in lung recipients. METHODS Lung recipients with an elevated DeMeester score (≥14.72) on post-transplant reflux testing between 2015 and 2020 were included. Patients were divided into 2 groups: group A (underwent surgery) and group B (medically managed). Endpoints were pulmonary function, allograft dysfunction-free survival and overall survival. Further analysis included subgroups: A1 (early surgery, <6 months) and A2 (late surgery, >6 months), and B1 (DeMeester <29.9) and B2 (DeMeester ≥30). RESULTS A total of 186 included subjects were divided into groups A [n = 46 (A1, n = 36; A2, n = 10)] and B [n = 140 (B1, n = 78; B2, n = 62)]. Compared to medically managed patients, patients who underwent surgery had a higher prevalence of hiatal hernia (P < 0.001) and a lower prevalence of oesophageal motility disorders (P = 0.036). Recipients who underwent surgery had superior pulmonary function at 5 years compared to group B (P < 0.05) and longer allograft dysfunction-free survival than subgroup B2 (P = 0.028). Furthermore, early surgery was associated with longer survival than late surgery (P = 0.021). CONCLUSIONS Antireflux surgery in recipients with reflux improved long-term allograft function, and early surgery showed a survival benefit. Allograft dysfunction-free survival of lung recipients who underwent surgery was significantly better than that of medically managed patients with DeMeester ≥30. We present an algorithm for appropriate selection of candidates for antireflux surgery after lung transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
- Creighton University School of Medicine, Phoenix Regional Campus, Phoenix, AZ, USA.
Zitieren
APA
Razia, D., Mittal, S. K., Fournier, S., Walia, R., Smith, M. A., Bremner, R. M., & Huang, J. L. (2023). Antireflux surgery versus medical management of gastro-oesophageal reflux after lung transplantation. European Journal of Cardio-Thoracic Surgery, 63(3). https://doi.org/10.1093/ejcts/ezad063
Vancouver
Razia D, Mittal SK, Fournier S, Walia R, Smith MA, Bremner RM, et al. Antireflux surgery versus medical management of gastro-oesophageal reflux after lung transplantation. European Journal of Cardio-Thoracic Surgery. 2023;63(3). doi:10.1093/ejcts/ezad063
BibTeX
@article{Razia2023,
author = {Razia, Deepika and Mittal, Sumeet K and Fournier, Sarah and Walia, Rajat and Smith, Michael A and Bremner, Ross M and Huang, Jasmine L},
title = {Antireflux surgery versus medical management of gastro-oesophageal reflux after lung transplantation},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2023},
volume = {63},
number = {3},
doi = {10.1093/ejcts/ezad063}
}
EUVIMED